Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Seth

Showing results (71-80 of 155) with videos related to

Pageof 16
Sort By:
Journal of Racial and Ethnic Health Disparities|February 11, 2016
Racial/Ethnic Differences in Labor Outcomes with Prostaglandin Vaginal InsertsMegan L Stephenson, J Seth Hawkins, Leo Pevzner, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1982
Prolactin response to metoclopramide in hyperthyroidismJ S Sawers, H A Kellett, N S Brown, et al.
Lancet (London, England)|September 27, 1975
Thyroid function in the long-term follow-up of patients treated with iodine-131 for thyrotoxicosisA D Toft, W J Irvine, J Seth, et al.
Lancet (London, England)|June 19, 1976
Letter: Hypothalamic/pituitary/adrenal function in patients receiving prednisolone and cytotoxic chemotherapyK S Wilson, J Seth, A C Parker, et al.
Clinical Endocrinology|October 1, 1983
Natural history of thyroid function in diabetics with impaired thyroid reserve: a four year controlled studyR S Gray, D Q Borsey, W J Irvine, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1974
Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosisA D Toft, W J Irvine, W M Hunter, et al.
Lancet (London, England)|September 22, 1973
Raised plasma-thyroid-stimulating-hormone levels in thyrotoxic patients treated with iodine-131A D Toft, W M Hunter, E W Barnes, et al.
Acta Endocrinologica|January 1, 1979
Failure of the TRH test to predict the clinical course of patients in remission after antithyroid drug therapy for Graves' diseaseW J Irvine, R S Gray, A D Toft, et al.
Journal of Clinical Pathology|March 1, 1992
Use of serum from patients with polycythaemia or haemochromatosis for laboratory external quality assurance exercisesJ I Craig, P L Yap, C Green, et al.
Lancet (London, England)|March 20, 1976
Hypothalamic/pituitary/adrenal function in patients treated with intermittent high-dose prednisolone and cytotoxic chemotherapyK S Wilson, C E Gray, E H Cameron, et al.
Pageof 16

Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Journal of Racial and Ethnic Health Disparities|February 11, 2016
Racial/Ethnic Differences in Labor Outcomes with Prostaglandin Vaginal InsertsMegan L Stephenson, J Seth Hawkins, Leo Pevzner, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1982
Prolactin response to metoclopramide in hyperthyroidismJ S Sawers, H A Kellett, N S Brown, et al.
Lancet (London, England)|September 27, 1975
Thyroid function in the long-term follow-up of patients treated with iodine-131 for thyrotoxicosisA D Toft, W J Irvine, J Seth, et al.
Lancet (London, England)|June 19, 1976
Letter: Hypothalamic/pituitary/adrenal function in patients receiving prednisolone and cytotoxic chemotherapyK S Wilson, J Seth, A C Parker, et al.
Clinical Endocrinology|October 1, 1983
Natural history of thyroid function in diabetics with impaired thyroid reserve: a four year controlled studyR S Gray, D Q Borsey, W J Irvine, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1974
Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosisA D Toft, W J Irvine, W M Hunter, et al.
Lancet (London, England)|September 22, 1973
Raised plasma-thyroid-stimulating-hormone levels in thyrotoxic patients treated with iodine-131A D Toft, W M Hunter, E W Barnes, et al.
Acta Endocrinologica|January 1, 1979
Failure of the TRH test to predict the clinical course of patients in remission after antithyroid drug therapy for Graves' diseaseW J Irvine, R S Gray, A D Toft, et al.
Journal of Clinical Pathology|March 1, 1992
Use of serum from patients with polycythaemia or haemochromatosis for laboratory external quality assurance exercisesJ I Craig, P L Yap, C Green, et al.
Lancet (London, England)|March 20, 1976
Hypothalamic/pituitary/adrenal function in patients treated with intermittent high-dose prednisolone and cytotoxic chemotherapyK S Wilson, C E Gray, E H Cameron, et al.
Pageof 16